设为首页 | 加入收藏| 旧站地址

扫描下面的二维码：

二维码

资讯

Summit dialogue Prof. Lai Wei VS Prof. Foster: I think we have two pegylated interferons which are currently available. One is the 40 kilo… 【详细】; 作者：发表时间：2009-02-15 16:04标签：专家访谈专家访谈其他肝病

国际肝病采访贾继东教授: APASL is one of the most important regional associations for the study of liver disease. It… 【详细】; 作者：贾继东发表时间：2009-02-15 15:02标签：图片专家访谈乙肝

APASL 2009大会主席致辞: We, the APASL, envisage, in the next ten years, the availability of new innovative approach… 【详细】; 作者：发表时间：2009-02-14 17:31标签：会议动态会议动态其他肝病

Focus on the Predictive Role of HCV RNA Monitoring: Professor Yu stated that individualized therapy has become a major consideration for clinic… 【详细】; 作者：发表时间：2009-02-14 17:05标签：热点聚焦热点聚焦丙肝

Could Lymphotropic-HCV Replication Affect the Development and Proliferation Activity of Human naive: There are many controversial studies about the existence of lymphotropic-HCV. Some group s… 【详细】; 作者：YasuteruKondo发表时间：2009-02-14 17:04标签：热点聚焦热点聚焦丙肝

Epidemiology of Non-alcoholic Fatty Liver Disease in the Asia-Pacific Region: There are few published data on the incidence of NAFLD worldwide. The incidence of US-defin… 【详细】; 作者：JiangaoFan发表时间：2009-02-14 17:01标签：热点聚焦热点聚焦脂肪肝

What Do We Know about the Difficult-to-Treat Patient with Chronic Hepatitis C Infection ?: Robert G. Gish 教授认为慢性丙型肝炎治疗的最终目标为在进展为肝硬化或肝细胞癌，在需要进行肝移植之前将患者治愈。【详细】; 作者：发表时间：2009-02-14 17:01标签：热点聚焦热点聚焦丙肝

Strengthening Investigation on the Role of HBV Resistance Monitoring: Professor Bowden pointed out that measurement of viral load was indispensable for monitorin… 【详细】; 作者：发表时间：2009-02-14 17:00标签：热点聚焦热点聚焦乙肝

Is There any Loophole in the Roadmap Model?: 于核苷（酸）类似物治疗慢性乙型肝炎的路线图概念（roadmap concept），Edward J. Gane教授认为存在以下几点漏洞【详细】; 作者：发表时间：2009-02-14 16:59标签：热点聚焦热点聚焦乙肝

Assessment of Nonalcoholic Fatty Liver Disease: Vincent W.S. Wong教授向我们介绍非酒精性脂肪性肝病(NAFLD)是最常见的全球性慢性肝脏疾病之一。单纯脂肪变性的患者预后较好，但非酒精性脂肪性肝炎（NASH）患者可能… 【详细】; 作者：发表时间：2009-02-14 16:54标签：热点聚焦热点聚焦酒精性肝病

Latest Study on Targeted Therapy for HCC: Finally, he concluded that since novel drugs needed to be tested in a common frame, a multi… 【详细】; 作者：发表时间：2009-02-14 16:54标签：热点聚焦热点聚焦肝癌

Comment on the Controversy in Guidelines of HBV Concurrent: The debate between Professor Schiff and Professor Jia brought us insight into the current s… 【详细】; 作者：JianSun发表时间：2009-02-14 16:53标签：热点聚焦热点聚焦乙肝

The Most Recent Progression of Ascites and SBP: 【详细】; 作者：发表时间：2009-02-14 16:51标签：热点聚焦热点聚焦肝硬化

Emphasizing the Significance of the Role of HBV DNA Monitoring: 慢性乙型肝炎治疗的目标为防止失代偿肝病的发生，这一目标可以通过清除或有效抑制病毒来达到。Jean-Michel Pawlotsky教授指出乙型肝炎病毒的监测包括：每3-6个月检测HB… 【详细】; 作者：发表时间：2009-02-14 16:48标签：热点聚焦热点聚焦乙肝

Nucleos(t)ide Analogs Can Be Stopped - PRO: Chronic hepatitis B is a prevalent disease worldwide, especially in Asia. Long term follow-… 【详细】; 作者：JidongJia发表时间：2009-02-14 16:48标签：热点聚焦热点聚焦乙肝

Strengthening Investigation on the Role of HCV RNA Monitoring: 【详细】; 作者：发表时间：2009-02-14 16:44标签：热点聚焦热点聚焦丙肝

Tenofovir in HBV treatment: Professor Marcellin concluded that TDF produced potent, continuous viral suppression and w… 【详细】; 作者：发表时间：2009-02-14 16:42标签：热点聚焦热点聚焦乙肝

Imaging in Hepatology: Generally speaking, there are 4 major areas of abnormality in the liver that we can make so… 【详细】; 作者：发表时间：2009-02-14 16:40标签：专家访谈专家访谈肝癌

easily be higher when long-term therapy is needed.: 聚乙二醇化干扰素（PEG-IFN）及核苷（酸）类似物为目前最主要的慢性乙型肝炎抗病毒治疗方法，在选择药物时需要考虑多个方面的因素。【详细】; 作者：发表时间：2009-02-14 16:39标签：热点聚焦热点聚焦乙肝

George K.K. Lau makes a speech in the Opening Ceremony: 【详细】; 作者：发表时间：2009-02-14 16:21标签：图片图片新闻其他肝病

首页前十页 531 532 533 534 535 536 537 538 539 540 后十页尾页

推荐标签更多 >>

栏目标签

领域标签

推荐文章